J&J Wins Trial Challenging Abbott Patents on Psoriasis Drug

Johnson & Johnson won its challenge to two Abbott Laboratories patents on antibodies that help curb the effects of the painful skin disease psoriasis.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.